Yan

International Editorial board member

Dr. Yan Li

  • Address : Deputy Chief Physician, Department of Pathology, Union Hospital, Tongji Medical College, China
  • E-Mail : liy10@mskcc.org

Research Interests :


Introduction


Dr. Yan Li is a highly accomplished physician and researcher with a strong background in Clinical Pathology and Pathology and Pathophysiology. Originating from Ning Xiang, China, Dr. Li earned both an MD in Clinical Medicine (2006) and a Ph.D. in Pathology and Pathophysiology (2011) from Tongji Medical College, Huazhong University of Science and Technology (HUST). Demonstrating commitment to the field, Dr. Li has been a licensed physician in China since 2008 and achieved Board Certification in Clinical Pathology in 2012.


Dr. Li's career trajectory showcases a dedication to both clinical practice and academic research, primarily focused in Pathology. Following post-graduate education, Dr. Li held academic and hospital appointments at Union Hospital, Tongji Medical College (HUST), including roles as an Attending and Deputy Chief Physician in the Department of Pathology. This period also included research appointments, progressing from Lecturer to Associate Professor in Pathology. Crucially, Dr. Li also broadened their research perspective with a two-year joint-training Ph.D. research fellowship in Cardiovascular Research at the Department of Anesthesia and Critical Care at Massachusetts General Hospital (MGH), Harvard Medical School.


Currently, Dr. Li is contributing to cutting-edge research as a Visiting Investigator in the Department of Surgery at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York, a position held since December 2019. This role, coupled with numerous publications in peer-reviewed journals, highlights a sustained focus on advanced medical science. Dr. Li is an active member of several professional bodies in the Chinese Medical Association and possesses fluency in both spoken and written English and Mandarin, facilitating broad collaboration within the medical and scientific communities.


AFFILIATION


Deputy Chief Physician

Department of Pathology

Union Hospital, Tongji Medical College

Huazhong University of Science and Technology

Wuhan

China

430022

Email : liy10@mskcc.org


RESEARCH IDS


# ID Type

RESEARCH INTERESTS


# Area
1. Clinical Pathology

PAPERS PUBLISHED


# Article Title Year
1. Li Y, Yu J, Li M, Qu Z, Ruan Q. Mouse mesenchymal stem cells from bone marrow differentiate into smooth muscle cells by induction of plaque-derived smooth muscle cells. Life Sci. 2011 Jan 17;88(3-4):130-40. 2011
2. Wang E, Feng Y, Zhang M, Zou L, Li Y, Buys ES, Huang P, Brouckaert P, Chao W. Toll-like receptor 4 signaling confers cardiac protection against ischemic injury via inducible nitric oxide synthase- and soluble guanylate cyclase-dependent mechanisms. Anesthesiology. 2011 Mar;114(3):603-13 2011
3. Li D, Yan D, Liu W, Li M, Yu J, Li Y, Qu Z, Ruan Q. Foxc2 overexpression enhances benefit of endothelial progenitor cells for inhibiting neointimal formation by promoting CXCR4- dependent homing. J Vasc Surg. 2011 Jun;53(6):1668-78 2011
4. Li Y, Si R, Feng Y, Chen HH, Zou L, Wang E, Zhang M, Warren HS, Sosnovik DE, Chao W. Myocardial ischemia activates an injurious innate immune signaling via cardiac heat shock protein 60 and Toll-like receptor 4. J Biol Chem. 2011 Sep 9;286(36):31308-19 2011
5. Yu J, Li Y, Li M, Qu Z, Ruan Q. Oxidized low density lipoprotein-induced transdifferentiation of bone marrow-derived smooth muscle-like cells into foam-like cells in vitro. Int J Exp Pathol. 2010 Feb;91(1):24-33.5 2010
6. Li M, Yu J, Li Y, Li D, Yan D, Qu Z, Ruan Q. CXCR4 positive bone mesenchymal stem cells migrate to human endothelial cell stimulated by ox-LDL via SDF-1alpha/CXCR4 signaling axis. Exp Mol Pathol. 2010 Apr;88(2):250-5 2010
7. Li M, Yu J, Li Y, Li D, Yan D, Ruan Q. CXCR4+ progenitors derived from bone mesenchymal stem cells differentiate into endothelial cells capable of vascular repair after arterial injury. Cell Reprogram. 2010 Aug;12(4):405-15 2010
8. Huang G, Xu M, Yu J, Meng H, Chen X, Li Y, Ruan QR. [Effect of silencing myocardin gene expression on differentiation of mouse bone mesenchymal stem cells into smooth muscle-like cells induced by PDGF-BB]. Zhonghua Bing Li Xue Za Zhi. 2009 Feb;38(2):117-20. Chinese 2009
9. Ruan QR, Li Y, Yan D. [Recent advances in studies on vascular progenitor cells]. Zhonghua Bing Li Xue Za Zhi. 2009 Aug;38(8):507-10. Chinese. 2009
10. Li Y, Qu ZL, Huang G, Meng H, Yu J, Ruan QR. [Expression of myocardin in differentiation of bone marrow-derived mesenchymal stem cells to smooth muscle cells]. Zhonghua Bing Li Xue Za Zhi. 2008 Oct;37(10):680-6. Chinese 2008

BOOKS PUBLISHED


# Title Publication Year

BOOK CHAPTERS PUBLISHED


# Chapter Title Book Title Publication Year

ACADEMIC PROFILE


# Examination Passing Year Country
1. Ph.D. 2011 China
2. MD (Clinical Medicine) 2006 China

EMPLOYMENT DETAILS


# Institution Position Country Service Period
1. Memorial Sloan Kettering Cancer Center Visiting Investigator United States 6 years, 5 months, 16 days
2. Union Hospital, Tongji Medical College Associate Professor China 5 years, 0 months, 30 days
3. Union Hospital, Tongji Medical College Lecturer China 3 years, 4 months, 29 days
Total Period : 14 years, 11 months, 15 days

PAPERS PRESENTED IN CONFERENCES



RESEARCH PROJECTS



MEMBERSHIPS



TRAINING PROGRAMS ATTENDED



HONOURS AWARDS AND DISTINCTIONS



EVENTS ATTENDED



EVENTS ORGANIZED